Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study

医学 内科学 化疗 肿瘤科 外科肿瘤学 阶段(地层学) 围手术期 癌症 疾病 人口 胃肠病学 外科 生物 环境卫生 古生物学
作者
Hyung‐Don Kim,Jong Seok Lee,Young Soo Park,Jeong Hwan Yook,Sung Hoon Noh,Youngkyu Park,Young‐Woo Kim,Sang Cheul Oh,Jong Gwang Kim,Min‐Hee Ryu,Jae‐Ho Cheong,Hyunki Kim,Joon Seok Lim,Jae-Hyuk Lee,Suk Hee Heo,Jin Young Kim,Mi Hwa Heo,Young Iee Park,Inho Kim,Yoon‐Koo Kang
出处
期刊:Gastric Cancer [Springer Science+Business Media]
卷期号:25 (6): 1039-1049 被引量:4
标识
DOI:10.1007/s10120-022-01325-6
摘要

In this post hoc analysis of the PRODIGY study, we aimed to investigate factors associated with survival outcomes and provide evidence for designing optimal perioperative treatment strategies for gastric cancer patients receiving neoadjuvant chemotherapy.A total of 212 patients in the neoadjuvant chemotherapy group of the PRODIGY study were included as the study population. The prognostic impact of clinicopathologic factors, including the initial radiological clinical stage (cStage) and post-neoadjuvant chemotherapy pathological stage (ypStage), was analyzed.The median age was 58 years. The majority of patients (77.4%) had cStage III disease, and about 10% and 25% had ypStage 0 and I disease, respectively. According to the initial cStage, progression-free survival (PFS) and overall survival (OS) were significantly different (P < 0.01). PFS and OS were also different according to the ypStage (P < 0.01). In multivariate analyses, cStage IIIC disease (vs. cStage II) and ypStage II and III disease (vs. ypStage 0/I) were independent factors for poor survival outcomes. Based on the patterns of PFS and OS according to both cStage and ypStage, three patient groups were defined. These groups showed distinct PFS and OS (P < 0.01) with 5-year PFS rates of 95.7%, 77.9%, and 31.3% and 5-year OS rates of 95.7%, 82.4%, and 42.5%, respectively.Both initial cStage and ypStage were independent factors for survival outcomes of gastric cancer patients treated with neoadjuvant chemotherapy. Efforts should be made to develop optimal peri-operative treatment strategies for patients at different risks according to cStage and ypStage.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wanmiao12完成签到,获得积分10
1秒前
yu发布了新的文献求助10
2秒前
mmmmm完成签到,获得积分10
3秒前
洁净白容完成签到,获得积分10
3秒前
大个应助孟孟采纳,获得10
3秒前
小镇的废物完成签到,获得积分10
3秒前
柴郡喵完成签到,获得积分10
4秒前
SYLH应助小熊采纳,获得10
5秒前
妹妹发布了新的文献求助10
5秒前
5秒前
赘婿应助我必定发nature采纳,获得20
6秒前
Ava应助kofbird采纳,获得50
7秒前
zz完成签到,获得积分10
7秒前
星辰大海应助ybwei2008_163采纳,获得10
7秒前
9秒前
9秒前
QJYKKK完成签到,获得积分10
9秒前
composite66完成签到,获得积分10
9秒前
ccchao发布了新的文献求助30
10秒前
充电宝应助十三采纳,获得10
10秒前
大个应助橙橙橙采纳,获得10
10秒前
Dandanhuang完成签到,获得积分10
10秒前
FashionBoy应助孟孟采纳,获得30
12秒前
畅快的刚完成签到,获得积分10
14秒前
14秒前
xxxx完成签到,获得积分10
14秒前
vain发布了新的文献求助10
14秒前
李健应助芒果小鹌鹑采纳,获得10
14秒前
cc完成签到,获得积分10
15秒前
这个名字是不是独一无二完成签到,获得积分10
15秒前
颗粒完成签到,获得积分10
16秒前
16秒前
javeeen完成签到,获得积分10
17秒前
应俊完成签到 ,获得积分10
17秒前
1234完成签到 ,获得积分10
18秒前
轻松元柏完成签到,获得积分10
19秒前
WN发布了新的文献求助10
19秒前
19秒前
我必定发nature给我必定发nature的求助进行了留言
20秒前
组织因子发布了新的文献求助10
20秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038569
求助须知:如何正确求助?哪些是违规求助? 3576279
关于积分的说明 11374944
捐赠科研通 3305979
什么是DOI,文献DOI怎么找? 1819354
邀请新用户注册赠送积分活动 892698
科研通“疑难数据库(出版商)”最低求助积分说明 815048